PuSH - Publikationsserver des Helmholtz Zentrums München

21 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Jian, Z.* et al.: Glycemic variability promotes both local invasion and metastatic colonization by pancreatic ductal adenocarcinoma. Cell. Mol. Gast. Hept. 6, 429-449 (2018)
2.
Kong, B.* et al.: A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling. Gut 65, 647-657 (2016)
3.
Kong, B.* et al.: Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy. Gut 67, 146-156 (2016)
4.
Kong, B.* et al.: Oncogenic Kras promotes early pancreatic carcinogenesis by perpetuating elements of natural inflammatory response. Pancreatol. 16, S. 11 (2016)
5.
Sunami, Y.* et al.: Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR. Hepatology 63, 1592-1607 (2016)
6.
Sunami, Y.* et al.: Canonical NF-kappa B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 63, 1, 233A-233A (2016)
7.
Berchtold, S.* et al.: Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Cancer Lett. 356, 721-732 (2015)
8.
Kong, B.* et al.: Metabolism gene signatures and surgical site infections in abdominal surgery. Int. J. Surg. 14, 67-74 (2015)
9.
Müller, S.* et al.: Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol. Cancer 14:94 (2015)
10.
Müller, S.* et al.: Erratum to: Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol. Cancer 14:144 (2015)
11.
Trajkovic-Arsic, M.* et al.: Multimodal molecular imaging of integrin αvβ3 for in vivo detection of pancreatic cancer. J. Nucl. Med. 55, 446-451 (2014)
12.
Kong, B.* et al.: Identification and characterization of an Aldh1a3-positive subtype of pancreatic ductal adenocarcinoma mediated by oncogenic Krasg12d/Erk-Mtor axis. Pancreas 42, 1360-1361 (2013)
13.
Kong, B.* et al.: Pancreatic progenitor expansion, mesenchymal cell proliferation and inflammation are required during early carcinogenesis. Pancreas 42, 1360 (2013)
14.
Grüner, B.M.* et al.: MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. PLoS ONE 7:e39424 (2012)
15.
Hösel, M.* et al.: Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 55, 287-297 (2012)
16.
Abiatari, I.* et al.: Moesin dependent cytoskeleton remodeling is associated with an anaplastic phenotype of pancreatic cancer. J. Cell. Mol. Med. 14, 1166-1179 (2010)
17.
Jiang, X.H.* et al.: Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer. Histol. Histopathol. 25, 1497-1506 (2010)
18.
Abiatari, I.* et al.: Consensus transcriptome signature of perineural invasion in pancreatic carcinoma. Mol. Cancer Ther. 8, 1494-1504 (2009)
19.
Erkan, M.* et al.: Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia 11, 497-508 (2009)
20.
Mihaljevic, A.L.* ; Esposito, I. ; Michalski, C.W.* ; Kleeff, J.* & Friess, H.*: Defining new pancreatic tumour entities by molecular analysis. Pancreatol. 9, 334-339 (2009)